WP
Westmount Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $929K | Sell |
5,003
-116
| -2% | -$21.5K | 0.26% | 78 |
|
|
2025
Q1 | $1.07M | Sell |
5,119
-26
| -0.5% | -$5.45K | 0.33% | 67 |
|
|
2024
Q4 | $914K | Sell |
5,145
-43
| -0.8% | -$7.64K | 0.28% | 71 |
|
|
2024
Q3 | $1.02M | Buy |
5,188
+16
| +0.3% | +$3.16K | 0.31% | 68 |
|
|
2024
Q2 | $881K | Buy |
5,172
+152
| +3% | +$25.9K | 0.29% | 71 |
|
|
2024
Q1 | $914K | Buy |
5,020
+2
| +0% | +$364 | 0.33% | 66 |
|
|
2023
Q4 | $778K | Sell |
5,018
-153
| -3% | -$23.7K | 0.32% | 71 |
|
|
2023
Q3 | $771K | Buy |
5,171
+458
| +10% | +$68.3K | 0.34% | 70 |
|
|
2023
Q2 | $635K | Sell |
4,713
-25
| -0.5% | -$3.37K | 0.28% | 79 |
|
|
2023
Q1 | $755K | Sell |
4,738
-25
| -0.5% | -$3.98K | 0.35% | 65 |
|
|
2022
Q4 | $770K | Buy |
+4,763
| New | +$770K | 0.4% | 59 |
|